Wellcare Announces Affordable 2027 Medicare Offerings with Integrated Care Solutions
Wellcare, a subsidiary of Centene Corporation (NYSE: CNC), has announced its 2027 Medicare Advantage and Prescription Drug Plan offerings ahead of the Annual Enrollment Period. The new portfolio emphasizes affordability, personalized support, and integrated care for beneficiaries, particularly those eligible for both Medicare and Medicaid. Wellcare's plans include two PDP options—Wellcare Classic and Value Script—with low-premium choices available nationwide across all 50 states. The company highlights its leadership in standalone Medicare Part D coverage with a network of over 60,000 pharmacies. Additionally, the portfolio includes Dual Eligible Special Needs Plan (D-SNP) products that make up nearly half of Wellcare's MA offerings and serve approximately 40% of their MA members. The plans also incorporate innovative benefits such as access to healthy foods through a Spendables® card for SSBCI-eligible individuals. Wellcare aims to simplify the healthcare experience by leveraging data-informed benefit design, supporting both medical needs and overall well-being while maintaining affordable coverage options.
Tickers: $CNC
Topics: Annual Enrollment Period Centene Corporation Medicare Advantage Prescription Drug Plan (PDP) Wellcare